Subcellular localization of survivin in non-small cell lung cancer

Chinese Journal of Cancer

Volumn 28, Issue 9, 2009, Pages

  He, Lang ^a,b   Hou, Mei ^a   Zhang, Jie ^a   Xu, Nie ^a   Chen, Ping ^a  

^a SICHUAN UNIVERSITY   (China)

^b Nanchong Central Hospital   (China)

Author keywords

BIRC5 protein; Immunohistochemistry; Non small cell lung cancer; Prognosis; Subcellular fractions

Indexed keywords

SURVIVIN; BIRC5 PROTEIN, HUMAN; INHIBITOR OF APOPTOSIS PROTEIN;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL NUCLEUS; CELLULAR DISTRIBUTION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SURVIVAL RATE; SURVIVAL TIME; FOLLOW UP; LUNG TUMOR; METABOLISM; MIDDLE AGED; PATHOLOGY; PRECANCER; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CELL NUCLEUS; CYTOPLASM; FEMALE; FOLLOW-UP STUDIES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; SURVIVAL RATE;

EID: 85046915572     PISSN: 1000467X     EISSN: 1944446X     Source Type: Journal    
DOI: 10.5732/cjc.009.10091     Document Type: Article

References (18)

1. Schild SE, Stella PJ, Geyer SM, et al. The outcome of combined-modality therapy for stage III non-small-cell lung cancer in the elderly [J]. J Clin Oncol, 2003, 21(17): 3186-3188.
2. Mountain CF, Dresler CM. Regional lymph node classification for lung cancer staging [J]. Chest, 1997, 111(6): 1718-1723.
3. Zhu ZH, Yang H, Fu JH, et al. Expression and prognostic value of survivin protein in early-stage non-small cell lung cancer [J]. Ai Zheng, 2007, 26(11): 1268-1271. [in Chinese]
4. Tanaka K, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas [J]. Clin Cancer Res, 2000, 6(1): 127-134.
5. Sah NK, Khan Z, Khan GJ, et al. Structural, functional and therapeutic biology of Survivin [J]. Cancer Lett, 2006, 244(2): 164-171.
6. Yonesaka K, Tamura K, Kurata T, et al. Small interfering RNA targeting survivin sensitizes lung cancer cell with mutant p53 to adriamycin [J]. Int J Cancer, 2006, 118(4): 812-820.
7. Li F. Survivin study: What is the next wave? [J]. J Cell Physio, 2003, 197(1): 8-29.
8. Chen YQ, Li DM, Cai YY, et al. The expression of survivin messenger RNA in sputum and cancerous tissue in human lung cancer [J]. Zhong Hua Jie He He Hu Xi Za Zhi, 2005, 28(4): 225-229.
9. Asanuma H, Torigoe T, Kamiguchi K, et al. Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells [J]. Cancer Res, 2005, 65(23): 11018-11025.
10. Akyürek N, Memi L, Ekinci Ö, et al. Survivin expression in pre-invasive lesions and non-small cell lung carcinoma [J]. Virchows Arch, 2006, 449(2): 164-170.
11. Li F, Yang J, Ramnath N, et al. Nuclear or cytoplasmic expression of survivin: what is the significance? [J]. Int J Cancer, 2005, 114(4): 509-512.
12. Mahotka C, Liebmann J, Wenzel M, et al. Differential subcellular localization of functionally divergent survivin splice variants [J]. Cell Death Differ, 2002, 9(12): 1334-1342.
13. Als AB, Dyrskjøt L, von der Maase H, et al. Emmprin and survivin predict response and survival following cisplatin-containing chemotherapy in patients with advanced bladder cancer [J]. Clin Cancer Res, 2007, 13(15 Pt 1): 4407-4414.
14. Sohn DM, Kim SY, Baek MJ, et al. Expression of survivin and clinical correlation in patients with breast cancer [J]. Biomed Pharmacother, 2006, 60(6): 289-292.
15. Ferrandina G, Legge F, Martinelli E, et al. Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters [J]. Br J Cancer, 2005, 92(2): 271-277.
16. Kennedy SM, O'Driscoll L, Purcell R, et al. Prognostic importance of Survivin in breast cancer [J]. Br J Cancer, 2003, 88(7): 1077-1083.
17. Vischioni B, van der Valk P, Span SW, et al. Nuclear localization of survivin is a positive prognostic factor for survival in advanced non-small-cell lung cancer [J]. Ann Oncol, 2004, 15(11): 1654-1660.
18. Lu B, Gonzalez A, Massion PP, et al. Nuclear Survivinas a biomarker for non-small-cell lung cancer [J]. Br J Cancer, 2004, 91(3): 537-540.